Pouyan Ebrahimi on Maternal Stroke: 270 Million Births, One Alarming Risk
Pouyan Ebrahimi, Medical Doctor and researcher at Babol University of Medical Sciences, shared on LinkedIn:
”270 Million Births, One Alarming Risk: Maternal Stroke
I am pleased to share our latest publication in BMC Pregnancy and Childbirth (Global incidence and risk factors of pregnancy-related stroke: a systematic review and meta-analysis of over 270 million women)
This study provides critical insights into the epidemiology and risk factors of maternal stroke.
Although my current research focus has shifted toward oncology, with the long-term goal of contributing to cancer treatment, there are moments when certain clinical questions still compel my curiosity.
One such question was how a condition as severe as stroke can affect nearly one in three pregnant women.
Our findings reveal that factors such as migraine, dyslipidemia, alcohol use, tobacco smoking, sickle cell disorders, coagulopathy, cardiovascular diseases, preeclampsia/eclampsia/gestational hypertension, and postpartum hemorrhage are significantly associated with increased stroke risk during pregnancy.
Sometimes, we tend to overlook the importance of certain conditions until their impact becomes undeniable.
I hope this study helps raise awareness about maternal stroke and inspires efforts to mitigate its preventable risk factors.
A special thanks to Springer and the dedicated reviewers for their valuable feedback and efforts in improving the quality of this work.”
Read the full article here.
Article: Global incidence and risk factors of pregnancy-related stroke: a systematic review and meta-analysis of over 270 million women
Authors: Malihe Nourollahpour Shiadeh, Kimia Pakdaman, Amin Esmaeilnia Shirvani, Zeinab Hashemi, Pouyan Ebrahimi
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells